-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharmanutra Nine-Month Net Profit Rises 21% Year-on-Year to EUR 17 Million

PUBT·11/09/2026 16:42:57
Listen to the news
Pharmanutra Nine-Month Net Profit Rises 21% Year-on-Year to EUR 17 Million
  • Pharmanutra’s net profit for the nine months ended September 2026 rose 21% year over year to EUR 17 million.
  • Sales climbed 17% year over year to EUR 110.9 million, while new business units contributed EUR 7.2 million.
  • Operating cash flow jumped 69% year over year to EUR 13.37 million; net financial position turned positive at EUR 5.4 million versus June.
  • October expansion included the launch of Sidevit B12 in Germany and SiderAL distribution in new international markets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmanutra S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 20106-33-2026_TELEBORSA.pdf), on November 09, 2026, and is solely responsible for the information contained therein.